财经首页
|
新浪首页
|
新浪导航
财经首页
美股首页
滚动
评论
经济数据
美股列表
中国概念股
美股行情中心
美股自选
(NBIX)
公司资讯
finviz | 2022年09月09日 07:54
Dow Jones Futures: Market Rally Runs To Key Resistance; 5 Stocks Flash Buy Signals
finviz | 2022年09月08日 01:03
Neurocrine Biosciences Looks Promising: Here's Our Trading Strategy
finviz | 2022年09月07日 04:01
Neurocrine Biosciences to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
finviz | 2022年09月06日 07:52
Dow Jones Futures Rise; Oil Prices Rally On Surprise OPEC+ Move, Russia News
finviz | 2022年09月03日 06:02
Dow Jones Futures: What To Do As Market Sell-Off Continues; Apple Leads 5 Stocks To WatchT
finviz | 2022年09月01日 10:26
Dow Jones Futures Fall As China Export Curbs On Nvidia, AMD Slam Chip Stocks
finviz | 2022年09月01日 06:14
Dow Jones Futures: Market Rally Fizzles Right Here; What To Do Now
finviz | 2022年09月01日 01:24
How IBD Stock Of The Day Neurocrine Bio Shrugged Off A High-Profile Failure
finviz | 2022年08月31日 00:23
Neurocrine Biosciences Buys UK-Based Hormone Therapy Player
finviz | 2022年08月06日 05:19
Neurocrine Shelves A Closely Watched Drug, But Stock Upbeat On Quarterly Win
finviz | 2022年08月05日 23:33
Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance
finviz | 2022年08月05日 13:48
Dow Jones Futures: Jobs Report Will Test 'Soft Landing' Market Rally; Tesla Stock Split Approved
finviz | 2022年08月05日 07:05
Sosei Heptares Oral, Selective M4 Receptor Agonist Advancing into Phase 2 Clinical Development under Multi-Program Collaboration with Neurocrine Biosciences
finviz | 2022年08月05日 05:15
Neurocrine Biosciences (NBIX) Reports Q2 Loss, Tops Revenue Estimates
finviz | 2022年08月05日 05:00
Neurocrine Biosciences Shelves Key Drug; Will It Overshadow The Earnings Beat?
finviz | 2022年08月05日 04:01
Neurocrine Biosciences Reports Second Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance
首页
 
上页
下页